Janssen
DARZALEX
Manufacturer:
Janssen
Name:
DARZALEX
Category:
J Code
HCPCS:
J9145
NDC(s):
57894-0502-05, 57894-0502-20,
Primary Type:
Cancer
Route of Administration:
Intravenous
About:
DARZALEX is a Cancer drug manufactured by Janssen and administered via the Intravenous route of administration. The J Code: J9145 is aligned to the drug DARZALEX.